Preparation of TAMIFLU for Oral Suspension. Emergency Compounding of an Oral Suspension from TAMIFLU Capsules (Final Concentration 15 mg/ml)

Similar documents
This letter is to notify you of recent changes to the TAMIFLU product monograph. Please note, additions/changes have been highlighted in yellow.

State of Tennessee Department Of Health Stockpile Antiviral Distribution

ﺮ ﺎ ﺻ ﻌﻣ ﻪﻫﺍ ﺒ ﺪ ﺍﻟ ﻓ

PRODUCT MONOGRAPH. Pr TAMIFLU. oseltamivir capsule 30 mg, 45 mg and 75 mg oseltamivir (as oseltamivir phosphate)

Instructions for Use NITYR (ni-tir) (nitisinone) tablets

PRODUCT MONOGRAPH. Pr TAMIFLU. oseltamivir capsule 30 mg, 45 mg and 75 mg oseltamivir (as oseltamivir phosphate)

PATIENT INFORMATION What is VITRAKVI? and and

TAMIFLU is absorbed to the key sites of influenza infection and treats the cause. Taking TAMIFLU means you feel better faster.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Vial. A healthcare provider should show you how to inject MYALEPT before you use it for

PATIENT INFORMATION. VALCYTE (Val-site) (valganciclovir) tablets

BAYER: KOGENATE FS WITH BIOSET (Recombinant FVIII)

MYALEPT (MAI-uh-lept) (metreleptin) for injection for subcutaneous use

HOW TO USE... 5mg. Pocket Guide

Rhino Clear Sprint Atomizer

Patient Information. EGRIFTA (eh-grif-tuh) (tesamorelin for injection) for subcutaneous use

Instructions for Use Enbrel (en-brel) (etanercept) for injection, for subcutaneous use Multiple-dose Vial

USER GUIDE. Melanotan must not be used if you are:

GET TO KNOW YOUR PEN. Needle cap. Rubber seal. Insulin scale. Pen cap. Cartridge holder Plunger. Insulin name. Dose window Dose. pointer.

Mixing Two Insulins. Getting Ready. What to Do

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

Blueberry scorch virus Reagent Set DAS ELISA, Alkaline phosphatase label for BlScV Catalog number: SRA 19100

INSTRUCTIONS FOR PREPARING AND GIVING AN INJECTION OF ENBREL POWDER

IMPORTANT: PLEASE READ. Don t

ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein INSTRUCTIONS FOR USE Do not Do not YOUR KIT CONTAINS:

Pfizer, BeneFIX R2 Recombinant Factor IX

PATIENT INFORMATION LEAFLET MEDICINE TO TREAT: DIABETES. Insulin

How to Use ENBREL : Vial Adapter Method

A step-by-step preparation guide

Insulin Basic facts. Patient Education Patient Care Services. What is insulin? What types of insulin are there? Basal Insulin

Preparing and Administering Medications Using ENFit : Procedure for Inpatient Settings

Reagent Set DAS ELISA, Alkaline phosphatase label SRA 22001, SRA 23203, SRA 27703, SRA & SRA ToRSV, ArMV, GFLV, AnFBV and PDV

A step-by-step preparation guide

PVY Reagent Set Compound ELISA, Alkaline phosphatase label Potato virus Y Catalog number: SRA 20001

SELF-INJECTION TRAINING GUIDE

Aac Reagent Set ELISA for the detection of Acidovorax avenae subsp. citrulli Catalog number: SRA 14800

GUIDELINES FOR THE USE OF INVICORP INJECTION FOR MEN WITH ERECTILE DYSFUNCTION.

Hosta virus X ELISA KIT

Experiment 1. Isolation of Glycogen from rat Liver

Package leaflet: Information for the user. GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon

Instructions for Use. For use with. 10 mg vial

TAMIFLU (oseltamivir phosphate) 1 of 30

INSTRUCTIONS FOR USE HUMIRA 40 MG/0.8 ML, 20 MG/0.4 ML AND 10 MG/0.2 ML SINGLE-USE PREFILLED SYRINGE

Potato leafroll virus (PLRV) Reagent Set DAS ELISA, Alkaline phosphatase label Catalog number: SRA List of contents

Practical 3 Extemporaneous Preparations Solutions. Name: Group: Date:

Reagent Set DAS ELISA, Alkaline phosphatase label

How should I take NUCYNTA oral solution?

Barley yellow dwarf virus Reagent Set Compound ELISA, Alkaline phosphatase label Catalog number: SRA (BYDV-MAV), SRA (BYDV-PAV)

Instructional Guide RECONSTITUTION OF IDELVION USING THE MIX2VIAL TRANSFER SET

INSTRUCTIONS FOR USE TYMLOS (tim lows ) (abaloparatide) injection, for subcutaneous use

Tube feeding with a nasogastric or nasojejunal tube

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ

CoaguChek S System. Quick Reference Guide. This is a CLIA-waived System. Coagulation Testing with Fresh Whole Blood

Ralstonia solanacearum PathoScreen Kit DAS ELISA, peroxidase label Catalog number: PSP 33900

Instructions for Use Enbrel (en-brel) (etanercept) Single-use Prefilled SureClick Autoinjector

Cereal yellow dwarf virus - RPV ELISA Kit

Tube Feeding Using the Gravity Method

How to use your gonal-f pre-filled pen

Emulsions. Purpose of emulsions and of emulsification:

Patient Education Pharmacy Services

MEDICATION GUIDE WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT MYALEPT? HOW SHOULD I USE MYALEPT? WHAT IS MYALEPT?

Standard operating procedures for preparation and administration of intramuscular injections. No Action Rationale

Instructions for Use Enbrel (en-brel) (etanercept) injection, for subcutaneous use Single-dose Prefilled Syringe

Oseltamivir phosphate capsule does not treat or prevent illness that is caused by infections other than the influenza virus.

Giving Medicine by Subcutaneous Injection

INFORMATION FOR THE CONSUMER

MEDICATION GUIDE. unusual darkening of the urine swelling of the stomach area (abdomen)

TAMIFLU Capsules contains the active ingredient oseltamivir

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LIQUID PREPARATIONS FOR ORAL USE

STEP-BY-STEP GUIDE TO SELF-INFUSION. Subcutaneous Administration of GAMMAGARD LIQUID

MODULE 3 How to Administer Medication

Tube Feeding With a Pump

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tamiflu 12 mg/ml powder for oral suspension oseltamivir

Anoro Ellipta Patient Handout

contains the active ingredient oseltamivir This leaflet answers some common questions about TAMIFLU oral suspension.

ALLMERCAP. Consumer Medicine Information (CMI) What is in this leaflet. What ALLMERCAP is used for. Before you take it

Diabetes Mellitus Insulin Treatment in Dogs

Division 1 Introduction to Advanced Prehospital Care

1 Before You Begin. Injection Instructions. Safety Tips. Disposing of Used Syringes, Needles, and Supplies. Having Someone Help You With Injections

How to Use Your Inhaler With a Spacer Device

Instruction Guide. Today is the day you change the way you live with dentures. How to Apply DenSureFit Soft Silicone Reline Material

OWNER MANUAL Diabetes in Cats

To provide you with necessary knowledge and skills to accurately perform 3 HIV rapid tests and to determine HIV status.

Ingredient Listing Qty. Unit NDC # Supplier. q.s. to ml

Lilly. Disposable Insulin Delivery Device User Manual

Experimental Procedure

Oral Dose of TAMIFLU for Treatment (twice daily for 5 days) of Influenza in Pediatric Patients One Year of Age and Older by

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tamiflu 12 mg/ml powder for oral suspension. oseltamivir

Gastrostomy Tube Feeding

Zucchini yellow mosaic virus ELISA Kit

Instructions For Use PRALUENT (PRAHL-u-ent) (alirocumab) Injection, for Subcutaneous Injection Single-Dose Pre-Filled Syringe (75 mg/ml)

Stability of Captopril in an Extemporaneously Compounded Humco s Oral Products

PLEASE READ THIS USER MANUAL BEFORE USE

PATIENT INFORMATION LEAFLET

APPENDIX 1 PROCEDURES FOR ADMINISTERING MEDICATION

Addendum to the 2016 FAO/WHO Manual on pesticide specifications: revised Tablet Specifications for DT, ST and WT

Package leaflet: Information for the user. Orfadin 4 mg/ml oral suspension nitisinone

Transcription:

Preparation of TAMIFLU for Oral Suspension It is recommended that TAMIFLU for Oral Suspension be constituted by the pharmacist prior to dispensing to the patient: 1. Tap the closed bottle several times to loosen the powder. 2. Measure 23 ml of water in a graduated cylinder. 3. Add the total amount of water for constitution to the bottle and shake the closed bottle well for 15 seconds. 4. Remove the child-resistant cap and push bottle adapter into the neck of the bottle. 5. Close bottle with child-resistant cap tightly. This will assure the proper seating of the bottle adapter in the bottle and child-resistant status of the cap. NOTE: SHAKE THE TAMIFLU FOR ORAL SUSPENSION WELL BEFORE EACH USE. The constituted TAMIFLU for Oral Suspension (12 /ml) should be used within 10 days of preparation; the pharmacist should write the date of expiration of the constituted suspension on a pharmacy label. The patient package insert and oral dispenser should be dispensed to the patient. Emergency Compounding of an Oral Suspension from TAMIFLU Capsules (Final Concentration 15 /ml) The following directions are provided for use only during emergency situations. These directions are not intended to be used if the FDA-approved, commercially manufactured TAMIFLU for Oral Suspension is readily available from wholesalers or the manufacturer. Compounding an oral suspension with this procedure will provide one patient with enough medication for a 5-day course of treatment or a 10-day course of prophylaxis. Commercially manufactured TAMIFLU for Oral Suspension (12 /ml) is the preferred product for pediatric and adult patients who have difficulty swallowing capsules or where lower doses are needed. In the event that TAMIFLU for Oral Suspension is not available, the pharmacist may compound a suspension (15 /ml) from TAMIFLU (oseltamivir phosphate) Capsules 75 using either of two vehicles: Cherry Syrup (Humco ) or Ora-Sweet SF (sugar-free) (Paddock Laboratories). Other vehicles have not been studied. This compounded suspension should not be used for convenience or when the FDA-approved TAMIFLU for Oral Suspension is commercially available. First, calculate the Total Volume of an oral suspension needed to be compounded and dispensed for each patient. The Total Volume required is determined by the weight of each patient. Refer to Table 7.

Table 7 Volume of an Oral Suspension (15 /ml) Needed to be Compounded Based Upon the Patient's Weight Body Weight Body Weight Total Volume to Compound per (kg) (lbs) patient (ml) 15 kg 33 lbs 30 ml 16 to 23 kg 34 to 51 lbs 40 ml 24 to 40 kg 52 to 88 lbs 50 ml 41 kg 89 lbs 60 ml Second, determine the number of capsules and the amount of vehicle (Cherry Syrup or Ora-Sweet SF) that are needed to prepare the Total Volume (calculated from Table 7: 30 ml, 40 ml, 50 ml, or 60 ml) of compounded oral suspension (15 /ml). Refer to Table 8. Table 8 Number of TAMIFLU 75 Capsules and Amount of Vehicle (Cherry Syrup OR Ora-Sweet SF) Needed to Prepare the Total Volume of a Compounded Oral Suspension (15 /ml) Total Volume of Compounded Oral Suspension needed to be Prepared 30 ml 40 ml 50 ml 60 ml Required number of TAMIFLU 75 Capsules Required volume of vehicle Cherry Syrup (Humco) OR Ora-Sweet SF (Paddock Laboratories) 6 capsules (450 8 capsules (600 10 capsules (750 12 capsules (900 29 ml 38.5 ml 48 ml 57 ml Third, follow the procedure below for compounding the oral suspension (15 /ml) from TAMIFLU Capsules 75 1. Carefully separate the capsule body and cap and transfer the contents of the required number of TAMIFLU 75 Capsules into a clean mortar. 2. Triturate the granules to a fine powder.

3. Add one-third (1/3) of the specified amount of vehicle and triturate the powder until a uniform suspension is achieved. 4. Transfer the suspension to an amber glass or amber polyethyleneterephthalate (PET) bottle. A funnel may be used to eliminate any spillage. 5. Add another one-third (1/3) of the vehicle to the mortar, rinse the pestle and mortar by a triturating motion and transfer the vehicle into the bottle. 6. Repeat the rinsing (Step 5) with the remainder of the vehicle. 7. Close the bottle using a child-resistant cap. 8. Shake well to completely dissolve the active drug and to ensure homogeneous distribution of the dissolved drug in the resulting suspension. (Note: The active drug, oseltamivir phosphate, readily dissolves in the specified vehicles. The suspension is caused by some of the inert ingredients of TAMIFLU Capsules which are insoluble in these vehicles.) 9. Put an ancillary label on the bottle indicating "Shake Gently Before Use". [This compounded suspension should be gently shaken prior to administration to minimize the tendency for air entrapment, particularly with the Ora-Sweet SF preparation.] 10. Instruct the parent or guardian that any remaining material following completion of therapy must be discarded by either affixing an ancillary label to the bottle or adding a statement to the pharmacy label instructions. Table 9 Dosing Chart for Pharmacy-Compounded Suspension from TAMIFLU Capsules 75 Body Weight (kg) Body Weight (lbs) Dose () Note: 1 teaspoon = 5 ml 30 15 kg 33 lbs 16 to 23 kg 24 to 40 kg 41 kg 34 to 51 lbs 52 to 88 lbs 89 lbs 45 60 75 Volume per Dose 15 /ml 2 ml 3 ml 4 ml 5 ml Treatment Dose (for 5 days) 2 ml two 3 ml two 4 ml two 5 ml two Prophylaxis Dose (for 10 days) 2 ml once 3 ml once 4 ml once 5 ml once Consider dispensing the suspension with a graduated oral syringe for measuring small amounts of suspension. If possible, mark or highlight the graduation corresponding to the appropriate dose (2 ml, 3 ml, 4 ml, or 5 ml) on the oral syringe for each patient. The dosing device dispensed with the commercially available TAMIFLU for Oral Suspension should NOT be used with the compounded suspension since they have different concentrations.

If you are taking TAMIFLU for Oral Suspension, your pharmacist will give you a dosing dispenser marked with three possible doses. Follow your healthcare professional s instructions on which dose to take or how to combine them for the proper dose for you. In order to be sure you receive the proper dose, it is important that you use the dispenser provided. Review the instructions below on how to use the dispenser and ask your pharmacist if you have any questions. If you lose or damage the dispenser and cannot use it, contact your healthcare professional or pharmacist for advice on the proper dose. If TAMIFLU for Oral Suspension is not available, your healthcare provider may instruct you to open TAMIFLU Capsules and mix the contents with sweetened liquids such as regular or sugar-free chocolate syrup. Please follow the dosing instructions below. How and where should I store TAMIFLU? TAMIFLU for Oral Suspension should be stored under refrigeration at 36º to 46ºF (2º to 8ºC). Do not freeze. DOSING INSTRUCTIONS FOR PATIENTS: How Do I Prepare TAMIFLU for Oral Suspension? Please follow instructions carefully to ensure proper dosing of the oral suspension. Shake closed bottle well for about 5 seconds before each use. Remove child-resistant cap. Before inserting the tip of the oral dispenser into bottle adapter, push the plunger completely down toward the tip of the oral dispenser. Insert tip firmly into opening of the bottle adapter. Turn the entire unit (bottle and oral dispenser) upside down.

Pull the plunger out slowly until the desired amount of medication is withdrawn into the oral dispenser (see figure). The 75 dose is obtained by filling the dispenser twice, once to the 30 graduation, and a second fill to the 45 graduation. Turn the entire unit right side up and remove the oral dispenser slowly from the bottle. Dispense directly into mouth. Do not mix with any liquid prior to dispensing. Close bottle with child-resistant cap after each use. Disassemble oral dispenser, rinse under running tap water and air dry prior to next use. If Directed by My Healthcare Provider, How Do I Mix the Contents of TAMIFLU Capsules with Sweetened Liquids? Please follow instructions carefully to ensure proper dosing. Holding one capsule over a small bowl, carefully pull the capsule open and pour the complete contents of the capsule into the bowl. Add a small amount of a sweetened liquid such as chocolate syrup (regular or sugar-free) that the child will consume completely. Stir the mixture and give the entire dose to the child.